All In Biotech

Drug Trial Radar · NCT03869437

RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI

Investigator Driven Randomized Controlled Trial of Cefiderocol Versus Standard Therapy for Healthcare Associated and Hospital Acquired Gram-negative Blood Stream Infection: Study Protocol (the GAME CHANGER Trial)

Last checked: Nov 20, 2026Latest source record: Feb 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 513 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

513

Actual

Start

Oct 28, 2019

Primary completion

Nov 13, 2023

Study completion Jan 29, 2024

Sponsor

Lead sponsor
The University of QueenslandAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Shionogi
First posted
Mar 11, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether a new antibiotic, Cefiderocol which works against a wide variety of gram negative bacteria, is equally effective as the antibiotics that are currently used as current standard of care.

Conditions

  • Bloodstream Infections

Interventions

  • CefiderocolDrug

    2 grams intravenously administered over 3 hours every 8 hours for a period of 5 to 14 days (dosage adjustment is necessary based on renal function).

  • Best Available TherapyOther

    Standard of care was determined by the investigator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mortality at 14 daysTime frame: 14 days post date of randomisation

Locations

19 sites in 6 countries. Site status is shown where the registry gives one.

  • Westmead Hospital

    Sydney, New South Wales, Australia

  • Princess Alexandra Hospital

    Brisbane, Queensland, Australia

  • Royal Brisbane and Womens Hospital

    Brisbane, Queensland, Australia

  • The Prince Charles Hospital

    Brisbane, Queensland, Australia

  • Austin Hospital

    Melbourne, Victoria, Australia

  • University of Malaya Medical Centre

    Kuala Lumpur, Malaysia

  • Universiti Sains Malaysia

    Kubang Kerian, Kelantan, Malaysia

  • Changi General Hospital

    Singapore, Singapore

  • National University Hospital Singapore

    Singapore, Singapore

  • Singapore General Hospital

    Singapore, Singapore

  • Tan Tock Seng Hospital

    Singapore, Singapore

  • Taichung Veterans General Hospital

    Taichung, Taiwan

  • National Cheng Kung University Hospital

    Tainan, Taiwan

  • Tri-Service General Hospital

    Taipei, Taiwan

  • Chang Gung Memorial Hospital

    Taoyuan, Taiwan

  • Ramathibodi Hospital

    Bangkok, Thailand

  • Siriraj Hospital

    Bangkok, Thailand

  • Khon Kaen University

    Khon Kaen, Thailand

  • Istanbul Medipol Üniversitesi

    Istanbul, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.